4Herrick J,Sciavl B. Ribonucleotide reductase and the reg- ulation of DNA replication:an old story and ancient herit- age [ J ]. Mol nicrobiol, 2007,63 ( 1 ) : 22-34.
5Rosell R, Cobo M, Isla D, et al. Pharmacogenomics and gemcitabine [ J]. Annals of Oncology,2006,17 : 13-16.
6Davidson JD, Ma L, Flagella M, et al. An increase in the expression of ribonucleotide reductase large subunit 1 is associated with gemcitabine resistence in non-small cell lung cancer cell lines [ J ]. Cancer Res, 2004,64 ( 11 ) : 3761-3766.
7Nakahira S, Nakamori S, Tsujie M, et al. Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer [ J ]. Int J Cancer,2007,120(6) :1355-1363.
8Staid K, Bergman AM, Eijk PP, et al. Micro-array analysis of resistance for gemcitabine results in increased expres- sion of ribonucleotide reductase subunits [ J ]. Nucleosides Nucleotides Nucleic Acids ,2006,25 ( 9-11 ) : 1001-1007.
9Bergman AM, Eijk PP, Ruiz van Haperen VW, et al. In vi- vo induction of resistance to gemcitabine results in in- creased expression of ribonucleotide reductase subunit M1 as the major determinant [ J ]. Cancer Res, 2005,65 (20): 9510-9516.
10Van de Wiel MA, Costa JL, Smid K, et al. Expression microarray analysis and oligo array comparative genomic hybridization of acquired gemcitabine resistance in mouse colon reveals selection for chromosomaI aberra- tions[ J ]. Cancer Res ,2005,65 (22) : 10208-10213.
4Ferry KV,Hamilton TC,Johnson SW.Increased nucleotide excision repair in eisplatin-resistant ovarian cancer cells:role of ERCCI-XPF.Biochem Phannaeol,2000,60(9):1305-1313.
5Azuma K,Komohara Y,Sasada T,et al.Excision repair crosscomplementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy.Cancer Sci,2007,98(9):1336-1343.
6Rosell R,Danenberg KD,Alberola V,et al.Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatintreated advanced non-small cell lung cancer patients.Clin Cancer Res,2004,10(4):1318-1325.
7Rosell R,Cuello M,Cecere F,et al.Usefulness of predictive tests for cancer treatment.Bull Cancer,2006,93(8):E101-E108.
8Ceppi P,Volante M,Novello S,et al.ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced nonsmall-cell lung cancer treated with cisplatin and gemcitabine.Ann Oncol,2006,17(12):1818-1825.
9Zhou W,Liu G,Park S,et al.Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer.Cancer Epidemiol Biomarkers Prey,2005,14(2):491-496.
10Zheng Z,Chen T,Li X,et al.DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer.N Engl J Med,2007,356(8):800-808.
